Scribd
Upload
189 views2 pages

Pfizer / Biontech

Pfizer partnered with BioNTech to develop a COVID-19 vaccine using BioNTech's mRNA technology. BioNTech is located in Germany and was founded by Turkish immigrants. Pfizer relied on BioNTech for its mRNA expertise to develop the vaccine. The partnership allowed the companies to pool resources and share risks and costs and benefits, helping Pfizer develop the vaccine faster. A major challenge is distributing the vaccine due to its cold storage requirements. Pfizer is implementing testing of distribution solutions like temperature monitors to address these challenges. The alliance benefits both companies through shared capabilities and mutual dependence.

Uploaded by

Akshaya Lakshminarasimhan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
189 views2 pages

Pfizer / Biontech

Pfizer partnered with BioNTech to develop a COVID-19 vaccine using BioNTech's mRNA technology. BioNTech is located in Germany and was founded by Turkish immigrants. Pfizer relied on BioNTech for its mRNA expertise to develop the vaccine. The partnership allowed the companies to pool resources and share risks and costs and benefits, helping Pfizer develop the vaccine faster. A major challenge is distributing the vaccine due to its cold storage requirements. Pfizer is implementing testing of distribution solutions like temperature monitors to address these challenges. The alliance benefits both companies through shared capabilities and mutual dependence.

Uploaded by

Akshaya Lakshminarasimhan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

Pfizer / BioNTech

 How did Pfizer get a head start in the Covid-19 vaccine race? What evidence is
there that Pfizer has made a big breakthrough?
 Who was Pfizer‘s partner? From this article and other sources, what do you know
about BioNTech? Where is the firm located and who are the firm's founders?
 What specific technology is this new vaccine based upon? Why did Pfizer rely
upon a partner to employ this technology rather than employ this technology on
its own to develop a vaccine?
 Broadly speaking, what does the story show about the importance of
international strategic alliances? How did the firm's web of
strategic partnerships worldwide result in a competitive advantage
for Pfizer?

Next Big Challenge After Covid-19 Vaccine Is Giving It to Enough People


 In the commercialization of its vaccine with BioNTech, which part of the value
chain does Pfizer have to manage? Is it easy or difficult to manage this part of the
value chain?
 What are some of the logistical challenges of distributing the vaccine? Especially
for the vaccine developed by BioNTech, why is distribution so difficult?
 How is Pfizer responding to these challenges? What kinds of experiments and
solutions is the firm implementing?
 Clearly Pfizer needed BioNTech to develop an mRNA–based vaccine.
Is it fair to say that BioNTech requires Pfizer just as much? Is this
mutual dependence helpful for maintaining equilibrium in the
relationship? Why? How?

 Broadly speaking, what does the story show about the importance of
international strategic alliances? How did the firm's web of
strategic partnerships worldwide result in a competitive advantage
for Pfizer?

• Importance of International Strategic alliances:


• This Strategic alliance between Pfizer and BioNtech can be viewed as one driving a
Radical Innovation, these Innovations are the ones that change the status quo
fundamentally, it is usually considered path-breaking.
• The alliances helps in acceleration of Innovation to the of find of the vaccine, through
the process efficiencies, Resource dependence ,Complementary resource alignment.
• By forming an alliance and combining the resources, the risk involved in the
development of the vaccine is distributed and the development is accelerated.

• For pfizer, the international alliances are a growth strategy that help in grooming their
core capabilities, gain access to new markets through their relationships with the
external environment. They work majorly on the Resource complementary where each
firm contributes to the dissimilar resources and capitalize their well-defined
competencies.

• Cost of production/operating

You might also like